Level A· Stronger Clinical Evidence

Rapid-acting pain relief in knee osteoarthritis: autologous-cultured adipose-derived mesenchymal stem cells outperform stromal vascular fraction: a systematic review and meta-analysis

Lee H., Lim Y., Lee S.H.

Analysed 31 studies with 1,406 patients: cultured ADMSCs reduced pain from month 3, whereas SVF reached significance only at 12 months.

Level A· Stronger Clinical EvidenceEvidence level of this study

Relatively higher-quality human studies compared with other topics in this database, e.g. multiple RCTs or systematic reviews. This does not mean it is standard or approved care.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide
Study type
Meta-analysis
Journal
Stem Cell Research & Therapy (2024)
Country
South Korea
Sample size
1406
Follow-up
3–12 months
PMID
39568086
DOI
10.1186/s13287-024-04034-2

What was studied

Compared onset and magnitude of effect between cultured ADMSCs and SVF.

Methods

  • • Multi-database search to June 2023, registered with PROSPERO (CRD42023433160).
  • • 19 studies with 958 patients entered the meta-analysis.

Key findings

  • • SVF produced significant pain reduction starting at 12 months (MD = -2.13).
  • • Both ADMSCs and SVF significantly improved knee function at 12 months.
  • • No evidence of severe adverse events directly linked to therapy.

Limitations

  • • Included both randomized and non-randomized studies with differing risk of bias.
  • • Cell preparation protocols differed across studies.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • Limited follow-up cannot indicate long-term outcomes.

Clinical interpretation

Suggests SVF may take longer to show pain benefit — important for setting patient expectations.

Evidence level: Stronger Clinical Evidence

View original source